[Intralesional methotrexate injection: an effective time and cost saving therapy alternative in keratoacanthomas that are difficult to treat surgically]. / Intraläsionale Methotrexat-Injektion. Eine wirkungsvolle, zeit- und kostensparende Therapiealternative bei operativ schwierig zu behandelnden Keratoakanthomen.
Hautarzt
; 51(8): 612-4, 2000 Aug.
Article
em De
| MEDLINE
| ID: mdl-10997318
ABSTRACT
A 53 year old female patient developed a keratoacanthoma, present on the left side of her nose for two months. After repeated unsuccessful trials with cryotherapy, she was treated with intralesional injection of methotrexate performed twice with a weekly internal. This led to complete resolution within 5 weeks. Although controlled studies on the effect of methotrexate in keratoacanthoma are not available, the rapid regression and the good cosmetic result suggest that this therapy may play a beneficial role in treating these lesions especially in problem locations.
Buscar no Google
Temas:
ECOS
/
Financiamentos_gastos
Bases de dados:
MEDLINE
Assunto principal:
Metotrexato
/
Fármacos Dermatológicos
/
Ceratoacantoma
Tipo de estudo:
Health_economic_evaluation
/
Observational_studies
/
Prognostic_studies
Limite:
Female
/
Humans
/
Middle aged
Idioma:
De
Revista:
Hautarzt
Ano de publicação:
2000
Tipo de documento:
Article